GB Sciences, Inc. (GBLX)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Mar 4, 2026, 9:30 AM EST
GB Sciences Employees
GB Sciences had 2 employees as of March 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
$48,618
Profits / Employee
-$527,753
Market Cap
153.72K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2024 | 2 | -1 | -33.33% | 2 | 0 |
| Mar 31, 2023 | 3 | -2 | -40.00% | 3 | 0 |
| Mar 31, 2022 | 5 | -25 | -83.33% | 3 | 2 |
| Mar 31, 2021 | 30 | 7 | 30.43% | 16 | 14 |
| Mar 31, 2020 | 23 | -33 | -58.93% | 23 | 0 |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Synairgen | 34 |
| Panbela Therapeutics | 8 |
| PaxMedica | 7 |
| Sigyn Therapeutics | 4 |
| Regen BioPharma | 1 |
| CNBX Pharmaceuticals | 1 |